View clinical trials related to Down's Syndrome.
Filter by:Down's syndrome is genetic disorder caused by trisomy 21. Children with Down's syndrome are characterized by awkward movements, gait, increased flexibility of joints, timing of mastering of basic skills, under development of fine motor skills. Virtual Reality Therapy (VRT) is a technique that uses interactive games as a physical therapy resource and has shown positive results in cortical reorganization, improving functional mobility, and quality of movement. This is an experimental study in which randomized controlled trials study design is being used.
This is a study to assess whether memantine is effective and safe in preventing age related cognitive deterioration and dementia in people with Down's syndrome (DS) age 40 and over. The study will last for a year and it will include 180 people with Down's syndrome with and without dementia. Participants will be assessed on memory skills, attention and problem solving abilities. Quality of life and abilities for everyday living skills will also be regularly checked. Primary Aims Clinical: - To determine the clinical efficacy of memantine versus placebo in preventing cognitive decline in people with DS. - To compare the safety and tolerability of memantine versus placebo in people with Down’s syndrome (DS). Biochemical and pathological: - To examine the ability of memantine to alter markers of disease progression in DS patients. Secondary Aims Clinical: - To determine whether memantine has, as compared with placebo, a significant positive impact on: - level of independent functioning as measured by the carer-rated adaptive behavioural scale, (ABS) in adults with DS; - quality of life in adults with DS. Biochemical and pathological: - To investigate putative markers of memantine’s mechanism of action in peripheral samples from living patients with DS.